Miach Orthopaedics
PrivateLast Round
Convertible Debt
May 1, 2026
Total Funding Raised
$92.72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Miach Orthopaedics operates in Healthcare & Life Sciences and is based in Westborough, Massachusetts. Its latest recorded funding round was a Series B Extension round in April 2024.
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to promote tissue growth and support connective tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sports & Fitness, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miach Orthopaedics Comparables
Compare Miach Orthopaedics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABANZA | 80% | |
| CoreTissue BioEngineering | 78% | |
| CONMED Corporation | 77% |
For institutional investors. Book with your work email.
Miach Orthopaedics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 1, 2026 | ||||
| Series B Extension | Apr 2, 2024 | ||||
| Series B | Jan 25, 2023 | ||||
| Debt | Jan 25, 2023 | ||||
| Series A Extension | Aug 4, 2021 | ||||
Series A | Sep 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Miach Orthopaedics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amzak Health | Series B Extension, Series B, Series A |
| SV Health Investors | Series B Extension |
| Major League Soccer Players Association | Series B Extension |
| Endeavour Vision | Series B Extension, Series B |
| Aperture Venture Partners | Series B Extension |
| DSM Venturing | Series B Extension, Series A, Series B |
| Sectoral | Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
Raised $6.5M in a Seed Round.
- Jul 14, 2025
Attended AOSSM 2025, highlighting BEAR(R) Implant evidence.
For institutional investors. Book with your work email.
Miach Orthopaedics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Miach Orthopaedics's valuation, stock price, and market status.
Is Miach Orthopaedics a public or private company?
Miach Orthopaedics is a private company.
What is the current stock price of Miach Orthopaedics?
Miach Orthopaedics is a private company, so its shares have no public market price. Caplight tracks Miach Orthopaedics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Miach Orthopaedics worth (valuation)?
Valuation information for Miach Orthopaedics is not publicly available.
Can I buy Miach Orthopaedics stock?
Miach Orthopaedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Miach Orthopaedics's last funding round?
Miach Orthopaedics's most recent funding round was Convertible Debt on May 1, 2026.
Who are the main investors in Miach Orthopaedics?
Key investors in Miach Orthopaedics include Amzak Health, SV Health Investors, Major League Soccer Players Association, Endeavour Vision, Sectoral.
Will Miach Orthopaedics IPO soon?
No public IPO plans have been announced for Miach Orthopaedics.
How can I track Miach Orthopaedics secondary market activity?
Caplight tracks bids, offers, and trades in Miach Orthopaedics's shares on secondary markets.